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Abstract
Background In this study, we specifically aimed to analyze
the technical and safety aspects of laparoscopic diverted
sleeve gastrectomy with ileal transposition (DSIT) in patients
with type 2 diabetes (T2DM).
Methods A total of 360 patients with type 2 diabetes who
underwent a DSIT procedure within the past 2-year period
(2011–2013) were analyzed. Operation time, length of hospi-
tal stay, perioperative and postoperative complications, and
mortality were recorded and analyzed.
Results The participants consisted of 229 males (63.6 %) and
131 females (36.4 %). Mean duration of follow-up was
12.4 months (range, 6–31). One early and two late mortalities
occurred. Early mortality was due to an anastomotic leak, and
late mortalities were related to myocardial infarction and a
traffic accident. Leakage and bleeding were the most common
surgical complications. The total number of surgical compli-
cations was 22 (6.1 %). Of those, 19 occurred within the first
month (early) and 3 occurred after the first month (late).
Among early complications, seven (1.94 %) required re-oper-
ation, two patients (0.55 %) required endoscopic treatment,
and the remaining ten were managed conservatively. Late
surgical complications (sleeve angulation) were noted in three
patients (0.83) and were treated by endoscopic stents.
Surgery-related non-surgical complications occurred in 19
cases (5.2 %), and neurological complications were noted in
11 patients (3.05 %). Additional surgical intervention was
required in 26 patients (7.22 %). Of those, 15 (4.16 %) re-
quired cholecystectomy.
Conclusions Our data demonstrate that DSIT is a technically
feasible operation and can be safely performed in type 2 dia-
betic patients with acceptable complication and mortality rates.
Keywords Laparoscopic diverted sleeve gastrectomy . Ileal
transposition . Type 2 diabetes
Introduction
The continuous increase in the prevalence of obesity and the
associated type 2 diabetes in the last two decades have evi-
dently reached the scale of a global epidemic. Thus, it is not
surprising to observe that currently, type 2 diabetes represents
the fifth leading cause of death in the USA [1]. Despite
escalating efforts to develop novel and effective medical and/
or behavioral therapeutic options for type 2 diabetes, at present,
only surgery can offer highest success rates with sustainable
results [2, 3]. However, this does not mean that the ultimate
surgical approach has been devised and standard surgical
techniques have been defined. On the contrary, a variety of
restrictive, malabsorptive, and/or combined techniques have
become a part of the growing trend of metabolic and bariatric
surgery and are increasingly more frequently used for a wider
range of body mass index (BMI) values than before for the
treatment of the dynamic, heterogeneous, and multifactorial
condition. Majority of the common techniques used in obese
diabetics have focused on easier and simpler methods,
consisting of either restriction or combination of restriction
with exclusion of the foregut. Malabsorptive techniques have
focused primarily on the hindgut stimulation. This results in a
great variation in the reported functional success rates, addi-
tional drug requirements, and the need for revisions.
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The risk of morbidity, mortality, and in particular digestive
or metabolic complications associated with surgery should
also be taken into consideration. Furthermore, several effects
commonly seen after surgery such as the change in eating
habits, nausea, and reflux should be carefully addressed, es-
pecially in terms of their effects on the quality of life. Also,
increased toilet regularity after malabsorptive surgeries can
seriously affect a patient’s social life [4].
Metabolic surgery is an evolving field of medicine where
novel surgical techniques are continuously being searched for
an acceptably sustainable metabolic outcome with minimal
mortality, perioperative morbidity, and lower risk of long-term
complications. An ideal or near-ideal procedure should also be
able to minimize the alterations in nutrition and quality of
ingestion and provide simple preventive and therapeutic strat-
egies for the non-morbidly obese diabetics who already have a
lower nutritional reserve compared to the morbidly obese
patients.
The efficacy and safety of laparoscopic diverted sleeve
gastrectomy with ileal transposition in diabetic patients with
lower BMIs have been previously shown [5, 6]. We hereby
document the outcomes in a wider range of patients and report
on mortality and mortality, with a special emphasis on non-
surgical complications.
Materials and Methods
Institutional ethical committee approval was obtained before
the study was commenced. In this report, we have retrospec-
tively analyzed our prospectively collected data on type 2
diabetic patients treated with laparoscopic diverted sleeve
gastrectomy with ileal transposition (DSIT) in a single “Cen-
ter of Excellence in Bariatric and Metabolic Surgery”, which
is a certified institution. A total of 454 patients were operated
under the same clinical and laboratory protocol between Oc-
tober 2011 and December 2013 by the same surgical team.
Inclusion criteria were as follows: a ≥3-year history of type
2 diabetes (T2DM) under stable medical treatment, HbA1c
>7 % for more than 3 months, weight stability defined as no
significant change (>3 %) of weight within the past 3 months,
and BMI above 25 kg/m2. Patients were excluded if they had a
BMI below 25 kg/m2, fasting C peptide level below 0.5 ng/ml,
or antiGAD antibody positivity. Other exclusion criteria in-
cluded previous major gastrointestinal surgery, pregnancy,
and inability to tolerate anesthesia. Patients with severe eating
problems and those on medications for eating disorders were
also excluded. A total of 360 patients followed up for 1 year
were finally included in the study.
The overall study population consisted of 360 poorly con-
trolled (mean HbA1c 9.41 %) diabetics (229 male, 63.6 %;
131 female, 36.4%) with a mean age of 51.2 years (range, 24–
79 years) and diabetes duration of 12.6 years (range, 3–
31 years). All patients were evaluated preoperatively by an
extended 3-day routine checkup, 1 month prior to surgery.
This evaluation included routine blood analysis and routine
electromyography (EMG), Doppler ultrasound examination
of the carotid arteries and lower extremities, echocardiography
(ECHO), and computed tomography angiography (CT-Angio)
of the coronary vessels. In total, there were 71 (19.7 %)
previous cardiovascular events. All cardiovascular events are
listed in Table 1. All patients underwent the same operation
(laparoscopic diverted sleeve gastrectomy with ileal transpo-
sition, (DSIT)) performed by the same team as previously
described [7]. Briefly, in this procedure, we start with a sleeve
gastrectomy or fundectomy (depending on the BMI) and
progress with duodenal transection 2–3 cm from the pylorus.
The sleeved stomach is transferred to the lower abdomen
through a transverse meso-colic opening. A single stay suture
is placed 50 cm from the ligament of Treitz, and the cecum is
identified. The last 30 cm of ileum is preserved, and a 170-cm
segment of the distal ileal segment is prepared for the anasto-
mosis. The first anastomosis is ileo-ileostomy, the second is
duodeno-ileostomy, and the third is ileo-jejunostomy. The first
and the last anastomoses are done in a functional side-to-side
manner, and the second anastomosis is done hand sewn with a
single-layer continuous 3/0 polydiaxanone (PDS) suture. All
the mesenteric defects are closed using 3/0 polypropylene
sutures. Schematic demonstration of the operation is shown
in Fig. 1. All patients operated after 2012 underwent routine
synchronous cholecystectomy. Eight patients underwent
additional Meckel’s diverticulectomy at the time of sur-
gery. None of them developed any postoperative com-
plications. A detailed record and analysis of all proce-
dures, including duration of surgery, perioperative, and
postoperative adverse events, were maintained. All pa-
tients received routine multivitamin supplements for at
least 6 months after surgery.
Table 1 Previous CVE events in our patients who underwent DSIT
Cardiovascular event N (%)
Atrial fibrillation 4 (1.1)
Compensated congestive cardiac failure 4 (1.1)
Moderate valvulopathy 4 (1.1)
Carotid stenosis 22 (6.1)
Previous myocardial infarction 5 (1.38)
Previous CABG 12 (3.3)
Previous coronary stent 18 (5)
Previous carotid surgery 2 (0.55)
Total 71 (19.7)
It should be noted that around 20 % of patients had a major cardiac or
vascular problem before surgery, demonstrating the heavy vascular bur-
den of our patient profile
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Results
A total of 360 patients followed up for 1 year were finally
included in the study. All patients had a BMI above 25 kg/m2.
Nearly one third of the patients (34.3 %) had a BMI above 35,
and two thirds (65.7 %) had a BMI below 35 kg/m2. Majority
of the patients (42 %) had a BMI between 30 and 35 kg/m2.
Patient distribution according to BMI and the percentage of
BMI loss (BMIL%) are shown in Table 2.
Improvement/remission in T2DM and in comorbidities
will be reported separately in another publication. Comorbid
conditions included hypertension in 226 patients (62.7 %),
hypercholesterolemia in 217 (60.27 %), and hypertriglyc-
eridemia in 170 subjects (47.2 %). End-organ damage was
noted in 84 patients (23.3 %), with 8 patients (2.2 %) having
nephropathy, 37 (10.27 %) retinopathy, and 39 (10.83 %)
severe, EMG proven neuropathy.
The outcomes are summarized in 5 categories: mortality
(A), surgical complications (B), surgery-related non-surgical
complications (C), neurological complications (D), and pa-
tients requiring additional surgery (E). Complications such as
diarrhea, excessive weight loss, reflux, and itching will be
discussed within the topic of surgery-related non-surgical
complications (B).
(A) Mortality: There were three mortalities. One patient died
20 days after surgery due to ileo-jejunal anastomotic
leak. One patient in complete remission died 8 months
after surgery due to myocardial infarction, and another
patient in complete remission died 13 months after
surgery in a traffic accident (he was not the driver).
Surgery-related mortality rate was 0.27 %.
(B) Surgical complications (N, 22; 6.1 %): In total, there
were 22 surgical complications (6.1 %). Of these, 8
(2.2 %) were leaks (4 anastomotic, 2 bile leaks, 2 duo-
denal stump leaks); 5 had bleeding (3 intra-abdominal, 2
intraluminal); 3 strictures (2 duodeno-ileal anastomotic,
1 biliary stricture); 3 sleeve angulations; 1 abscess; 1
wound infection; and 1 deep vein thrombosis. Among
the 22 patients with surgical complications, 7 patients
required immediate surgical re-intervention (1.94 %).
The remaining 15 were managed conservatively. There
was no sleeve leak and nomesenteric herniation. Table 3
shows the nature and the number of the surgical
complications.
(C) Surgery-related non-surgical complications (N, 20;
5.5 %): We observed surgery-related non-surgical com-
plications in 20 cases. The most frequent complaint was
the change in bowel habits, reported by ten patients
(2.77 %). Diarrhea occurred in seven patients and con-
stipation in three. We observed food intolerance (with-
out a mechanical reason) occurring in five, excessive
weight loss (without nausea and vomiting) in two, in-
tractable reflux in one, hypoglycemia in one, and itching
in one case. Surgery-related non-surgical complications
are shown in Table 4.
(D) Neurological complications (N, 11; 3.05 %): Totally, 11
patients had neurological complications. Two patients
complained worsening of amnesia and another three
complained worsening of polyneuropathy (PNP). Three
patients experienced a unilateral foot drop (peroneal
palsy) that responded to medical treatment, and another
Fig. 1 Schematic demonstration of the operation. a Sleeve gastrectomy.
b Duodenal transection. c Inframesocolic transfer of the sleeve. d
Interposition of the ileal segment between distal stomach and the
proximal jejunum
Table 2 Changes in BMI were analyzed using four BMI subcategories: BMI <30 kg/m2, BMI=30–34.9 kg/m2, BMI=35–39.9 kg/m2, and BMI>
40 kg/m2. Increasing BMI was associated with a tendency towards more weight loss, as expected
BMI <29.9 BMI=30–34.9 BMI=35–39.9 BMI>40
Mean preoperative BMI 27.9 kg/m2 32.1 kg/m2 37.2 kg/m2 43 kg/m2
Mean postoperative BMI 21.63 kg/m2 24.19 kg/m2 26.79 kg/m2 29.8 kg/m2
Change in mean BMI 6.27 kg/m2 7.91 kg/m2 10.41 kg/m2 13.2 kg/m2
Percentage change in BMI (BMIL%) 22.4 % 24.64 % 27.98 % 30.3 %
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three patients had a cerebrovascular event. None of them
were fatal. Neurological complications are shown in
Table 5.
(E) Additional surgical intervention (N, 26; 7.22%): In total,
26 patients required an additional surgical procedure
after the DSIT. Of those, 15 were cholecystectomy, 2
were appendectomy, 2 were re-operation due to intra-
abdominal enlarged lymph nodes, 1 was coronary artery
bypass grafting (CABG); also, 1 patient required surgery
for spinal conditions, 1 for frozen shoulder, 1 for toe
amputation (burn injury), 1 for abscess and necrosis in
the leg (after drug injection), 1 (a female patient) needed
a curettage, and another underwent body-contouring
surgery. List of patients requiring additional surgery is
depicted in Table 6.
The mean operative time, including cholecystectomy was
3.9 (range, 3.1 to 8.2) hours. Mean length of hospital stay was
6.9 days (min 4, max 42). Except for the above-listed compli-
cations, no other complications commonly seen in bariatric
surgery such as parenchymal organ injury/bleeding, marginal
ulcer, sleeve leak, and particularly mesenteric herniation oc-
curred. Twenty-nine of 360 patients (8.1 %) were re-admitted
for food intolerance and dehydration. Before surgery, 24 pa-
tients (6.7 %) had iron deficiency anemia and 87 patients
(24.2 %) had vitamin D deficiency, while 22 patients
(6.1 %) had iron deficiency anemia and 71 patients (19.7 %)
had vitamin D deficiency after surgery.
Discussion
In this paper, all complications that have occurred during a 2-
year period in patients undergoing DSIT have been reported.
The data presented involve only those subjects with at least
6 months of follow-up. Our results show a surgical complica-
tion rate of 6.1 % and a mortality rate of 0.27 % in our study
group. The metabolic outcomes of DSIT have been previously
reported [5–7], and the metabolic outcomes in our study will
be subjected to future publications. Thus, we have initially
intended to report the surgical outcomes for an intervention
blamed for surgical complexity. The results presented herein
demonstrate a fairly high morbidity rate compared to other
bariatric procedures (particularly non-stapled/non-anastomot-
ic procedures) [8, 9]. There was only one mortality within the
first month among 360 patients, corresponding to a mortality
rate of 0.27 %. This figure is similar to the mortality rates of
common bariatric procedures (0.2–0.5 %), which is similar to
the mortality rates associated with elective laparoscopic cho-
lecystectomy [10]. The mortality in our series was due to an
anastomotic leak (ileo-jejunostomy = third anastomosis). This
anatomical site represents the junction between the alimentary
and biliopancreatic limbs. Not surprisingly, leaks in this
Table 3 A total of 22 surgical complications occurred among 360 patients undergoing DSIT
Surgical complications: n, 22 (6.1 %)
Leak: n, 8 (2.2 %) Bleeding: n, 5 (1.38 %) Infectious: n, 2 (0.55 %) Stricture/angulation:
n, 6 (1.38 %)
Other: n, 1
(0.27 %)
Anastomotic leak: 4 (1.1 %) Intra-abdominal: 3 (0.83 %) Abdominal abscess: 1 (0.27 %) Anastomotic: 2 (0.55 %) DVT: 1 (0.27 %)
Duodenal stump leak: 2 (0.55 %) Intraluminal: 2 (0.55 %) Wound infection: 1 (0.27 %) Biliary stricture: 1 (0.27 %)
Bile leak: 2 (0.55 %) Sleeve angulation: 3 (0.83 %)
The most frequent complicationwas leak (2.2 %), followed by bleeding (1.38%), stricture or sleeve angulation (1.38%), and DVT (0.27%). Abdominal
abscess occurred in the second patient with duodenal stump leak, and the patient developed abscess despite adequate drainage and antibiotic coverage.
Bile leaks resulted from misplaced cystic duct clips in one case and a Luschka leak in the second. There were no sleeve leaks and no mesenteric hernia
Table 4 The most common non-surgical complaint was a change in
bowel movements that occurred in 10 subjects
Surgery-related non-surgical complications: n, 20 (5.5 %)
Change in bowel movements: n, 10 (2.77 %)
Food intolerance (without a mechanical reason): n, 5 (1.38 %)
Excessive weight loss (without nausea and vomiting): n, 2 (0.55 %)
Intractable reflux: n, 1 (0.27 %)
Itching: n, 1 (0.27 %)
Hypoglycemia: n, 1 (0.27 %)
Among them, seven had diarrhea and three had constipation. In total, two
cases had a BMI below 20 kg/m2 4 and 5 months after surgery, respec-
tively. These patients were hospitalized and received appropriate treat-
ment. Six months after surgery, they both reached a BMI above 20 kg/m2 .
Other rare complications were reflux, itching, and hypoglycemia
Table 5 The total rate of neurological complications was
approximately 3 %
Neurological complications: n, 11 (3.05 %)
Cerebrovascular event: n, 3 (0.83 %)
Foot drop (peroneal palsy): n, 3 (0.83 %)
Worsening of polyneuropathy: n, 3 (0.83 %)
Worsening of amnesia: n, 2 (0.55 %)
Of note, two patients developed a hemorrhagic and one patient developed
an ischemic cerebrovascular event. None of them were fatal. All cases
responded to medical treatment and physiotherapy
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junction are known to be associated with higher mortality
rates due to the chemical properties of the biliary and pancre-
atic juices [11]. The patient who died of the leak was diag-
nosed on the morning of the first postoperative day and was
promptly taken to the operation room (OR). The leak was
closed with 3/0 PDS sutures using the routine closure tech-
nique; the cavity was washed and drained sufficiently. How-
ever, the patient developed omental necrosis 3 days after the
revision surgery and did not respond to repeated laparotomies.
He died 20 days after the initial procedure.
In total, there were four anastomotic leaks (1 ileo-ileal and
3 jejunoileal). As previously stated, one patient with
jejunoileal leak died, and other three patients recovered fully
after the revision surgery, all of which involved laparoscopic
procedures.
Other surgical complications included bleeding, infections,
strictures, and deep vein thrombosis. Most common compli-
cations reported after bariatric operations are anastomotic
leak, hemorrhage, wound infection, and pulmonary events
[12]. This is similar to our findings except for pulmonary
events. No major pulmonary events occurred in our patients.
All operations in our participants were performed
laparoscopically, and all patients underwent a comprehensive
checkup program 1 month before surgery, including pulmo-
nary function tests and pulmonary examination. All patients
with an underlying pulmonary problem received a 1-month
treatment protocol monitored by PEF meter and this routine
procedure assisted in the identification of any pulmonary
disturbances that may interfere with the outcome.
Two of our patients experienced a bile leak from the
duodenal stump, and both were managed conservatively. An-
other two had bile leakage, one from the cystic duct
(misplaced clips) and one from a Luschka channel after diffi-
cult simultaneous cholecystectomy, and these were repaired
surgically. Initial procedures did not involve routine simulta-
neous cholecystectomy with DSIT. However, 15 out of initial
61 cases had several problems or developed gallbladder
stones, and therefore, we then started to perform routine
simultaneous cholecystectomy. Even the leak rates in chole-
cystectomy performed by the junior members of the surgical
team at the final stage of surgery were 0.62 %, which is
comparable to those observed in elective cholecystectomy
[10]. In total, we had three cholecystectomy-related compli-
cations (two leaks, one stricture). Other complications includ-
ed one case of wound infection and one case of deep vein
thrombosis. When these five patients were excluded, the
resultant surgery-related technical complication rate was
4.72 % (17/360).
There were two anastomotic strictures, both of which were
localized at the duodeno-ileostomy site (second anastomosis).
In our routine surgical practice, this anastomosis is performed
using a single-layer continuous hand-sewn technique with 3/0
PDS. Vascular supply to the duodenal end of the stomach is
solely dependent on the left gastric artery. It is not uncommon
to observe a bluish duodenal end while doing this anastomo-
sis. But, stricture requiring stenting occurred in two cases
(0.55 %). One male patient totally improved after a single-
coated stent application. The other case, a female patient, had
an anatomic abnormality whereby the left gastric artery was
arising from the hepatic artery. In order to take down the
sleeved stomach to the lower abdomen, we routinely sacrifice
the right gastric artery, which probably was the dominant
artery to the stomach. This might have interfered with the
anastomotic blood supply. She re-developed a stricture after
the initial stent and developed an anastomotic tear during the
application of the second stent. She was taken to the operation
room, tear was drained, and a partially covered stent was
placed. She did very well after the second stent.
We also had partial sleeve angulation in three cases all of
which allowed the advancement of the endoscope for a 1.5-cm
diameter length and were treated with endoscopic stent place-
ment. The remaining surgical complications included one
wound infection and one deep vein thrombosis. Both were
managed conservatively.
We also had non-surgical complications, mainly related to
the changes in bowel habits occurring in less than 3 % of the
whole patient population. The most frequent complaint was
diarrhea followed by constipation. Majority of bowel com-
plaints improved with medical treatment and diet, with lesser
Table 6 Of the 26 cases referred for additional surgery, 15 required
cholecystectomy leading to a decision to incorporate routine
cholecystectomy into the primary surgical intervention
Additional surgical interventions: n, 26 (7.22 %)
Cholecystectomy: n, 15 (15/61=24.6 %)
Appendectomy: n, 2 (0.55 %)
Abdominal enlarged lymph nodes: n, 2 (0.55 %)
Abscess and necrosis of the leg: n, 1 (0.27 %)
Spine surgery: n, 1 (0.27 %)
Frozen shoulder: n, 1 (0.27 %)
Toe amputation: n, 1 (0.27 %)
CABG: n, 1 (0.27 %)
Curettage: n, 1 (0.27 %)
Abdominoplasty, mammoplasty: n, 1 (0.27 %)
Initially, 61 patients did not undergo cholecystectomy on the basis of
normal ultrasonographic findings; however, 15 (24.6 %) of these required
cholecystectomy within a mean period of 1 year. Therefore, we switched
to a routine cholecystectomy after these initial cases. Two patients pre-
sented with abdominal pain, food intolerance, and mesenteric enlarged
lymph nodes, with poor response to antibiotic and other medical treat-
ments. These were operated; their lymph nodes were removed and
examined pathologically. No specific cause could be identified. Leg
abscess and necrosis occurred in a patient after analgesic injection which
were treated by repeated wound debridement. Toe amputation was per-
formed 6 months after surgery due to a burn injury in a severely diabetic
patient who was in complete remission. One patient underwent body-
contouring surgery 18 months after DSIT
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requirement for medication and severity of complaints over-
time. Patients with food intolerance required hospitalization,
and oral or IV supplementation was administered. This prob-
lem also tended to improve with time. In total, only two
patients (0.55 %) suffered from diarrhea that lasted more than
1 year. The occurrence of nocturnal diarrhea in these two
patients points out to a possibility of autonomic neuropathy,
rather than steatorrhea [13]. We also believe that itching may
also represent a form of neuropathy [14, 15], since no hepatic,
renal, or other obvious causes could be identified. Three
percent of our patients had neurological complications. These
cases were suffering from diabetic neuropathy on the back-
ground of long-existing diabetes (mean 12.4 years) and insulin
use. Amnesia is a well-documented effect of repeating hypo-
glycemia, which, in our cases, might be attributable to the
consequence of the disease itself [16, 17].
Despite the presence of data indicating improvement in
diabetic neuropathy after gastric bypass surgery [18], we
observed EMG-confirmed worsening PNP in three cases
(0.83 %), all under complete diabetic remission after surgery.
Neuropathy after bariatric surgery is an extremely rare com-
plication occurring in less than 0.1 % of cases and is usually
associated with severe weight loss, nausea, and vomiting [19,
20]. Osteomalacia and other forms of nutritional deficiencies
as well as acute normalization of dysglycemia in some cases
have been proposed to play a role in the development of
neuropathies after bariatric surgery [21–23]. Our patients ex-
perienced worsening of the already existing PNP, rather than
new onset PNP. Furthermore, they were within the first
6 months after surgery and had good food tolerance. None
of them had nausea or vomiting and were receiving prophy-
lactic multivitamin and mineral supplements. We believe that
the acute glycemic regulation might have played a role in our
patients. An additional three patients experienced a unilateral
foot drop (peroneal palsy) within the first 3 months after
surgery that was probably due to sudden weight loss, rather
than vitamin or mineral deficiency [24, 25]. They responded
well to medical treatment and healed without any sequela.
Finally, another three patients experienced a cerebrovascular
event, one ischemic, and two hemorrhagic. None of them
were fatal. These three patients had had all components of
the metabolic syndrome, one had a previous history of MI,
and two had carotid stenosis.
In these patients, an important indicator of the safety of this
procedure is the requirement for additional surgery in the long
term. None of our patients needed a revisional surgery. How-
ever, one fourth of the initial 61 cases (15/61, 24.6%) required
a cholecystectomy within 2 years after the initial surgery,
despite treatment with oral ursodeoxycholic acid. Two cases
presented with pericholecystic abscess. Therefore, we
switched to routine cholecystectomy after this initial group
of patients. In addition to cholecystectomy, a variety of other
surgical interventions were performed. Only two cases
underwent laparoscopic exploration due to abdominal pain
and enlarged mesenteric lymph nodes. The number of addi-
tional surgical procedures performed was 17 in 360 patients
(4.72 %). The remaining were two appendectomies, one
CABG, one spinal surgery, one surgery for frozen shoulder,
one for toe amputation (burn injury), and one for abscess and
necrosis in the leg (after drug injection). One patient presented
with uterine wall thickening and required curettage. DePaula
et al. recently published their paper in 2012 with 39 months of
follow-up after DSIT in patients with T2DM and BMI <35
with a mortality rate of 1 % and major morbidity rate of 8.4 %
with an early control of postprandial glycemia. This does not
seem to compare favorably to published morbidity/mortality
rates regarding the sleeve and gastric bypass [26].
It is well established that patients with metabolic syndrome
have a predisposition for the development of gallstones and
gallstone formation after bariatric surgery [27–29]. Despite
the use of routine postoperative ursodeoxycholic acid treat-
ment, we have noted a high incidence of gallstone formation
in our initial patient group consisting of 61 subjects, and
therefore, we switched to routine cholecystectomy. Apart from
gallbladder-related problems, patients undergoing bariatric
surgery may develop incisional, ventral, trocar, and internal
hernias requiring surgery [30–32]. No herniations were ob-
served in our patients. Finally, one major reason for additional
surgery after bariatric or metabolic operation is the reconstruc-
tive or body-contouring surgery [33]. In our series, only one
female patient underwent abdominoplasty and mammoplasty
18 months after DSIT.
The main limitation of our study group was our average
hospital stay which seems almost three times longer than cur-
rently published hospital stays in regard to the gastric bypass and
sleeve gastrectomy. This increase in hospital stay could lead to
increase hospital costs. Although we mentioned the obesity
epidemic with reference to disease rates in the USA, the patients
included in this study show lowBMI. This disparity between the
impact of type 2 diabetes in lower BMI patients fromTurkey and
India versus those from the USA, where bariatric surgery is not
readily approved for patients whose BMI is between 25 and
34.9, needs to be emphasized to justify the morbidity/mortality
rate accepted for this procedure when compared to that of the
natural course of disease in these countries.
The results of this retrospective study clearly demonstrate
that DSIT operation can be safely performed in overweight,
obese, and morbidly obese type 2 diabetic patients. More
objective criteria are certainly necessary for a comparative
assessment of different operational techniques and for surgical
training to clarify when and who should perform this
operation.
In conclusion, after a follow-up ofmore than 1 year, DSIT has
been shown to be a relatively safe surgical alternative for the
treatment of T2DM patients with a wide range of BMI. Further
studies are warranted to assess the efficacy, patient selection
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criteria, and cost-effectiveness of the procedure and its effects on
reproducible weight loss and resolution or improvement of
obesity-related comorbidities especially in long term.
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